Estudio retrospectivo, no intervencionista, unicéntrico para describir una cohorte española de pacientes con FMF e identificar pacientes tratados de manera subóptima con mínima actividad de la enfermedad y su impacto en la CVRS (Calidad de vida relacionada con la salud).
Datos básicos
- Protocolo:
- CACZ885NES01R
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2023
- Año de finalización:
- 2024
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
CLINICAL VARIABILITY IN PATIENTS DIAGNOSED OF JUVENILE IDIOPATHIC ARTHRITIS WITH POSITIVE AND NEGATIVE ANTINUCLEAR ANTIBODIES (ANA)
Torrat Noves, A. M.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.5203. 2023
Childhood-Onset Non-Infectious Uveitis in the "Biologic Era". Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings.
Mesa-Del-Castillo P; (...); Sánchez Sevila JL
Article. 10.1080/09273948.2024.2336609. 2024
Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-alpha inhibitor initiation in children in Spain.
Calzada-Hernandez, Joan; (...); Noguera-Julian, Antoni
Article. 10.1007/s00431-022-04640-3. 2022
HOW TO DIAGNOSE: JUVENILE PSORIATIC ARTHRITIS. MULTICENTER PROSPECTIVE OBSERVATIONAL STUDY IN CHILDREN WITH SUSPECTED DIAGNOSIS
Palmou-Fontana, N.; (...); Collado, P.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.1883. 2023
INSIGHTS FROM A NOVEL MONOGENIC AUTOIMMUNE DISEASE: OVERVIEW OF A MULTICENTRIC EUROPEAN COHORT OF 27 PATIENTS WITH COPA SYNDROME
David-Gabarre, C.; (...); Fremond, M. L.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3505. 2023
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Brunner, Hermine I; (...); De Benedetti, Fabrizio
Article. 10.1093/rheumatology/keae180. 2024
Long-term efficacy/safety of canakinumab in patients with tumor necrosis factor receptor-associated periodic syndrome: results from a phase III trial.
Gattorno, Marco; (...); Lachmann, Helen
Article. 10.1002/art.42695. 2023
Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept.
Brunner, Hermine I; (...); Ruperto, Nicolino
Article. 10.1002/acr.25156. 2023
MUSCULOSKELETAL INVOLVEMENT IMPAIRS QUALITY OF LIFE IN JUVENILE PSORIATIC ARTHRITIS
Collado, P.; (...); Lopez Robledillo, J. C.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3892. 2023
Pharmacokinetic, Pharmacodynamic, and Safety Profile of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: Analysis of Data from a Multicenter, Open-Label Trial
Brunner, Hermine; (...); Wilde, Paul
Meeting Abstract. 2023
Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain.
Antón J; (...); Calvo Penadés I
Article. 10.36469/001c.85088. 2023
What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment
Murias, Sara; (...); Anton, Jordi
Article. 10.1016/j.reuma.2021.12.003. 2023
What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment.
Murias, Sara; (...); Anton, Jordi
Article. 10.1016/j.reumae.2022.11.002. 2023